• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • Opinion
    • The future of US aid

    Opinion: The new US development agency could be a game-changer for health innovation

    As the leaders of the new U.S. International Development Finance Corporation start laying the groundwork for an investment strategy, they should look toward health as a key priority, writes PATH CEO Steve Davis.

    By Steve Davis // 01 November 2019
    At a meeting of the South African Medical Research Council, Chris de Villiers of Sinapi Biomedical gives a presentation on a low-cost uterine balloon tamponade, developed in collaboration with PATH. Photo by: PATH / Patrick McKern

    A signature effort of the Trump administration to bring more private sector capital and ingenuity into its global development efforts has unfortunately fallen victim to congressional gridlock. With another stopgap funding measure, the widely anticipated launch of the U.S. International Development Finance Corporation, or DFC, was stalled from its Oct. 1 deadline.

    Experts from across sectors herald this new agency, which was created last year with bipartisan support in Congress and in close coordination with the Trump administration. Many agree it has real promise, thanks to its mandate to engage the private sector in U.S. global development efforts and the pipeline of promising investment opportunities on the horizon.

    Catch up on US DFC

    ► Exclusive: New US DFC will be 'proactive, forward-leaning and strategic' says new CEO

    ► Opinion: We need to get the new US DFC over the finish line. Here's why.

    ► Failure to launch: Why congressional budget drama delayed US DFC

    As the leader of PATH, a global health innovation organization, I am excited by the potential for the DFC to unlock capital for investments to improve the quality of life for billions and bring about sustainable economic development. I hope Congress and the administration will come together to provide the necessary resources and authorities to get the DFC launched.

    That’s just the first step. Even now as the DFC leaders start laying the groundwork for an investment strategy, they should look toward health as a key priority.

    Few areas offer as much opportunity as health. A healthy population is the foundation of a healthy economy. Nearly one-quarter of all economic growth is attributable to health system strength. Conversely, poor health is one of the greatest economic barriers in low- and middle-income countries. For example, malaria costs African countries up to $12 billion annually in lost productivity. Put frankly, healthy populations drive economic vitality. That’s why the U.S. government has made global health a key component of efforts to move countries along the “journey to self-reliance,” with the goal of reducing the need for foreign assistance.

    By deploying new financing models — including much-needed blended finance options that combine public and philanthropic resources to mobilize private capital — the DFC has the power to bring in a range of new partners to advance health innovation.

    To have the greatest impact — on saving and improving lives and on reducing the need for U.S. assistance — consider these best bets:

    Digital health. Digital technology holds incredible promise for health: It offers new ways to increase access, improve health outcomes, and lower costs. It can yield data to help stop outbreaks before they reach a crisis level, accelerate life-or-death care decisions, and provide policymakers with data on where to spend limited resources. There is a clear need — and promising investment opportunity — in health data infrastructure. Investments in digital health help achieve better health outcomes and can also reduce costs.

    Local innovation. Reaching the worst pockets of poverty and overcoming weaknesses in health systems will demand new technologies. In low-income countries around the world, innovators and entrepreneurs are designing new tools to meet local health needs that also carry relevance for the world. Though the pipeline of innovations is strong, a lack of access to capital and technical assistance frequently prevents ideas from coming to life. At PATH, we see this challenge firsthand in impact hubs we’ve started in South Africa and India to incubate products from “lab to market.” For example, we helped Sinapi Biomedical, a South African device manufacturer, advance a lifesaving tool to stop bleeding after childbirth. It has now been cleared for sale in markets in Africa and Europe. The DFC should explore opportunities to invest in specific new health tools as well as to assist local innovators in navigating the confusing, complicated path to bring a product to market.

    Local manufacturing. Localization of production for health products — including drugs, vaccines, diagnostics, and devices — in lower-income countries can decrease costs, ensure adequate supply, and bring new capabilities and opportunities for local companies. For example, PATH developed the first vaccine designed specifically for use in Africa to protect against a deadly strain of meningitis that plagued the sub-Saharan region. By 2020, the vaccine is expected to have prevented 400 million cases of meningitis. Our partner on the vaccine, the Serum Institute of India, gained new capacity and expertise, allowing it to expand its vaccine production. Though the potential economic yield is great, manufacturing operations are capital-intensive, creating a high barrier to entry. Financing these investments through the DFC, paired with technical assistance to expand capabilities and quality, would have the dual impact of improving health and building critical infrastructure for a strong economy.

    New tools, developed and scaled locally, can help bring health within reach for people around the world. This can also support countries that are recipients of U.S. assistance to grow into stronger economic partners. I hope Congress and the administration will come together to fully fund the DFC so it can begin this important work.

    • Banking & Finance
    • Global Health
    • Innovation & ICT
    • PATH
    • United States
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
    The views in this opinion piece do not necessarily reflect Devex's editorial views.

    About the author

    • Steve Davis

      Steve Davis

      As president and CEO of PATH, Steve Davis combines his extensive experience as a technology business leader, global health advocate, and social innovator to lead PATH's work to accelerate lifesaving ideas and bring new health solutions to scale. PATH and our partners reach an average of 150 million people per year with innovative technologies and approaches that improve health and save lives.

    Search for articles

    Related Jobs

    • Individual Consultant: Hospital Planner
      Ulan Bator, Mongolia | Mongolia | East Asia and Pacific
    • Individual Consultant: Health Service Needs Assessment Consultant
      Mongolia | East Asia and Pacific
    • Individual Consultant: Market Assessment Expert (International)
      Apia, Samoa | Port-Vila, Vanuatu | Samoa | Vanuatu | East Asia and Pacific
    • See more

    Most Read

    • 1
      Opinion: Mobile credit, savings, and insurance can drive financial health
    • 2
      Strengthening health systems by measuring what really matters
    • 3
      Opinion: India’s bold leadership in turning the tide for TB
    • 4
      Opinion: Why vision is key to unlocking global development potential
    • 5
      How AI-powered citizen science can be a catalyst for the SDGs

    Trending

    Financing for Development Conference

    The Trump Effect

    Newsletters

    Related Stories

    The future of US AidMemo lays out plan to replace USAID with new humanitarian agency 

    Memo lays out plan to replace USAID with new humanitarian agency 

    Sponsored by Gates FoundationOpinion: Enlightened self-interest demands global health investments

    Opinion: Enlightened self-interest demands global health investments

    Sponsored by Gates FoundationCan health survive the development finance revolution?

    Can health survive the development finance revolution?

    The Future of US aidOpinion: US foreign assistance recasting is a test of national strategy

    Opinion: US foreign assistance recasting is a test of national strategy

    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement